Convection and retro-convection enhanced delivery: some theoretical considerations related to drug targeting.
Delivery of drugs and macromolecules into the brain is a challenging problem, due in part to the blood-brain barrier. In this article, we focus on the possibilities and limitations of two infusion techniques devised to bypass the blood-brain barrier: convection enhanced delivery (CED) and retro-convection enhanced delivery (R-CED). CED infuses fluid directly into the interstitial space of brain or tumor, whereas R-CED removes fluid from the interstitial space, which results in the transfer of drugs from the vascular compartment into the brain or tumor. Both techniques have shown promising results for the delivery of drugs into large volumes of tissue. Theoretical approaches of varying complexity have been developed to better understand and predict brain interstitial pressures and drug distribution for these techniques. These theoretical models of flow and diffusion can only be solved explicitly in simple geometries, and spherical symmetry is usually assumed for CED, while axial symmetry has been assumed for R-CED. This perspective summarizes features of these models and provides physical arguments and numerical simulations to support the notion that spherical symmetry is a reasonable approximation for modeling CED and R-CED. We also explore the potential of multi-catheter arrays for delivering and compartmentalizing drugs using CED and R-CED.
Joint Graduate Group in Bioengineering, University of California at San Francisco and Berkeley, San Francisco, California 94143-0446, USA.
J P Michael
JP
Motion
Grace H
GH
Huynh
Francis C
FC
Szoka
Ronald A
RA
Siegel
D000970:Antineoplastic Agents / Q000008:administration & dosage* / Q000378:metabolism; D001812:Blood-Brain Barrier / Q000187:drug effects / Q000378:metabolism; D001932:Brain Neoplasms / Q000188:drug therapy* / Q000378:metabolism; D018481:Convection; D016503:Drug Delivery Systems / Q000379:methods*; D057446:Hydrodynamics; D008954:Models, Biological
D000970:Antineoplastic Agents